ArticleAlzheimer's & dementia (New York, N. Y.)

Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer's disease drug candidate CT1812.

Valentina Di Caro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.